Skip to main content
. 2002 Mar 1;22(5):1922–1928. doi: 10.1523/JNEUROSCI.22-05-01922.2002

Table 1.

Part one: performance during phase 2 of the delay radial maze task, third assessment

No cannula PBS Scop 6.31 μg Scop 10.00 μg Scop 15.85 μg
Arm visits before an error 3.91 ± 0.29 2.05 ± 0.48 1.45 ± 0.39 1.40 ± 0.35 1.25 ± 0.38
Mean total number of errors 2.04 ± 0.29 4.50 ± 0.87 4.70 ± 0.64 6.10 ± 0.93 5.20 ± 0.77
Errors to first six phase 1 arms (during phase 2) 1.48 ± 0.22 3.70 ± 0.67 3.50 ± 0.50 4.35 ± 0.60 3.75 ± 0.53
Errors to remaining six baited phase 2 arms (during phase 2) 0.56 ± 0.14 0.80 ± 0.30 1.20 ± 0.27 1.75 ± 0.39 1.45 ± 0.29

Arm visits before an error, mean total number of errors, errors made to the first six arms (phase 1), and errors made to the remaining six baited arms (phase 2) ± SEM after no cannula– infusion-free (No cannula), PBS only (PBS), and three doses of scopolamine (Scop 6.31 μg, Scop 10.00 μg, and Scop 15.85 μg). Infusion volume was 0.15 μl/side.